Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Esophageal Neoplasms × toripalimab × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Triple Negative Breast Neoplasms 1 SCLC, Extensive Stage 1 Melanoma 1 Lung Neoplasms 1 Liver Diseases 1 Esophageal Neoplasms 1 Breast Neoplasms 1 Advanced Colorectal Carcinoma 1

Interventions

Esophagectomy 13 Blood Specimen Collection 10 Surgical Procedures, Operative 8 Radiotherapy 8 Surveys and Questionnaires 5 Endoscopic Mucosal Resection 5 Specimen Handling 4 Neoadjuvant Therapy 4 Drug Therapy 4 Biopsy 4 Tissue Banks 3 Psychiatric Rehabilitation 3 Positron Emission Tomography Computed Tomography 3 Observation 3 Magnetic Resonance Spectroscopy 3 Immunohistochemistry 3 Endoscopy 3 Diffusion Magnetic Resonance Imaging 3 Breath Tests 3 anlotinib 2 Polymerase Chain Reaction 2 Platinum Compounds 2 Paclitaxel 2 Immunotherapy 2 Gastroscopy 2 Fiducial Markers 2 Endoscopic Ultrasound-Guided Fine Needle Aspiration 2 Dynamic Contrast Enhanced Magnetic Resonance Imaging 2 Amplified Fragment Length Polymorphism Analysis 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06009705 2023-08-24

Best-EEC

Hebei Medical University Fourth Hospital

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡